Replies to post #2079 on Algernon Pharmaceuticals Inc (AGNPF)

[shell3]

Management has recently presented our plans to the Board on the results of our business analysis to determine our primary focus for product development. The Board will analyse this information and meet with Management to make a final decisions on which diseases will be our primary focus in developing a breath analyser.
http://thecse.com/sites/default/files/Breathtec_-_CSE_Form_7_-_Monthly_Progress_Report_for_July_2017-Completed.pdf